clinical trial · NCT07222098
A Clinical Study of Calderasib (MK-1084) With Rosuvastatin and Metformin in Healthy People (MK-1084-016)
Merck Sharp & Dohme LLC·phase1·completed·n = 16
HealthyRosuvastatinMetforminCalderasib
brief summary
Researchers want to learn about calderasib when given with rosuvastatin and metformin in healthy people. The goal of this study is to compare the amount of rosuvastatin and metformin in a person's body over time when given with and without calderasib
started
Nov 19, 2025
primary completion
Dec 14, 2025
completion
Dec 29, 2025
last updated
May 6, 2026
official title
An Open-Label, 2-Period, Crossover Study to Evaluate the Effects of a Single Dose of MK-1084 on the Single-Dose Pharmacokinetics of Rosuvastatin and Metformin in Healthy Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol